Livongo Health Inc

Livongo is the consumer digital health company that empowers people with chronic conditions to live a better life. It has developed a completely new approach for diabetes management that combines the latest technology with coaching. By offering the right information, tools, and support, at the right time, we provide our members with real-time, personalized insights, and support to make diabetes management easier. Its approach is leading to better financial and clinical outcomes while also creating a better experience for people with diabetes and their care team of family, friends, and medical professionals.  It was founded in 2008 and is headquartered in Mountain View, California.

Teladoc

Teladoc Health Inc's (NYSE: TDOC) acquisition of Livongo Health (NASDAQ: LVGO) was completed on Oct. 30 and has yet to generate impressive growth, according to Goldman Sachs. The Teladoc Health Analyst: Robert Jones initiated coverage of Teladoc Health with a Neutral rating and $206 price target.

Why Goldman Sachs Is Waiting For Teladoc's Merger Story To Unfold

All the forecasted future benefits, at least over the next three to five years, is already price into the TDOC stock price today. The post Teladoc's Merger With Livongo Is Closed, But TDOC Stock Reflects All Its Value appeared first on InvestorPlace.

Teladoc's Merger With Livongo Is Closed, But TDOC Stock Reflects All Its Value

What do you get when you combine two companies sporting triple-digit revenue gains? A bright future.

What Teladoc and Livongo Health's Explosive Results Mean For Success Post-Merger

The company is a more formidable competitor in virtual care with Livongo under its wing.

3 Compelling Reasons to Buy Teladoc Stock Now That the Livongo Deal Is Done

Sometimes triple-digit revenue growth just isn't good enough.

Teladoc and Livongo Demolished Expectations. So Why Are Their Stocks Down?

BioMarin Pharmaceutical

Eastman Kodak

Many of us want to forget this year, but investors in these three companies will be especially eager to put 2020 in the rearview mirror.

2020 Will Be a Year to Forget for These 3 Healthcare Stocks

Is (LVGO) Outperforming Other Medical Stocks This Year?

Is Livongo Health (LVGO) Stock Outpacing Its Medical Peers This Year?

We believe shares are significantly undervalued and the market is underestimating the accretion from Livongo. Q3 results were strong, Teladoc beat EPS and revenue estimates for the quarter, and management guided FY results up - a positive revision.

Teladoc: Excellent Quarter With Q4 Upside From Livongo

Here's why two businesses that were already successful in their own niches felt a need to come together.

The 1 Reason Why Teladoc Health and Livongo Were So Eager to Merge

On the heels of an anticipated $18.5 billion mega-merger with chronic disease management firm Livongo, Teladoc witnessed surging demand for its virtual care services in Q3 2020: It conducted 2.8 million visits, marking a 206% year-over-year increase from Q3 2019. Further, the company boasted $289 million in Q3 2020 revenue—exceeding Wall Street estimates of $282 million, per Fierce Healthcare.

Teladoc reported impressive Q3 earnings ahead of its $18.5 billion mega-merger with Livongo

In both cases, over 99% of participants voted thumbs-up for the deal.

Teladoc and Livongo Health Shareholders Approve the Companies' Merger

Ardagh Group

Brandywine Realty

Berry Global Group

Brighthouse Financial

Brookfield Property REIT

salesforce.com

NortonLifeLock

NRG Energy

Peloton

QuidelOrtho Corp

Tesla

Zoom Video

These are the stocks with the best value, fastest growth, and most momentum for November.

Top Stocks for November 2020

Triple-digit revenue growth apparently wasn't enough to send shares higher when the two companies reported earnings on Wednesday.

Why Teladoc and Livongo Health Stocks Fell on Thursday

Livongo Health (LVGO) delivered earnings and revenue surprises of 300.00% and 11.02%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Livongo Health (LVGO) Beats Q3 Earnings and Revenue Estimates

MOUNTAIN VIEW, Calif., Oct. 28, 2020 (GLOBE NEWSWIRE) -- Livongo Health, Inc. (NASDAQ: LVGO), the leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced financial results for its third quarter ended September 30, 2020.

Livongo Reports Third Quarter 2020 Financial Results

Livongo's news of a mega merger with Teladoc made waves late this summer. Investors talking about the risks of the deal may have good reason to do so.

Why Is Everyone Talking About Livongo Health Stock?

Boston Scientific

Cerner

Penumbra

In Q3, Medical Product stocks are expected to have gained from gradual lifting of restrictions in many states and regions. However, international sales might have been dampened.

Medical Products Q3 Earnings on Oct 28: BSX, CERN & More

Livongo Health's (LVGO) third-quarter results are likely to reflect growth in core Livongo for Diabetes solution.

Livongo Health (LVGO) to Post Q3 Earnings: What's in Store?

Datadog

Fastly

Cloudflare

Boston Beer Company

Block

Trade Desk

Twilio

"Since we created the Cramer Covid-19 index six months ago, the stay-at-home, work-at-home stocks just have not been able to quit," the "Mad Money" host said.

Jim Cramer reviews top 10 winners on his Cramer Covid-19 index

Livongo Health (LVGO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Livongo Health (LVGO) Reports Next Week: Wall Street Expects Earnings Growth

Livongo Health (LVGO) closed at $142.75 in the latest trading session, marking a -0.39% move from the prior day.

Livongo Health (LVGO) Stock Sinks As Market Gains: What You Should Know

Financial Twitter is abuzz about these high-growth companies.

5 of the Most Talked-About FinTwit Stocks

The fast-growing chronic disease management company is getting swallowed up in one of the largest deals of the year, but it may not be too late to pick up shares.

Is It Too Late to Buy Livongo Stock?

JACKSONVILLE, Fla., Oct. 16, 2020 /PRNewswire/ -- GuideWell Mutual Holding Corporation (GuideWell), the parent to a family of forward-thinking companies focused on transforming health care, announced a strategic agreement today with Livongo (Nasdaq: LVGO) the leading Applied Health...

Livongo Signs Strategic Partnership with GuideWell Accelerating Care Delivery to Vulnerable Populations

Here's how it could shift the future of the entire healthcare industry.

News for Livongo Health Inc Stock (LVGO)